PON1 and Alzheimer disease: Exposure to organophosphates is associated with lower PON1 activity [85] and has been linked to neurological disorders including AD, Parkinson’s disease (PD), intellectual disability, attention deficit hyperactivity disorder (ADHD), autism, and other developmental neuropathies [90].